JP Morgan, AbbVie vet takes helm at Amgen-partnered neuroscience startup


A 20-year veteran of JP Morgan who went on to become AbbVie's chief strategy officer is now making the leap to early-stage biotech.

Previous Stock Yards Bank opening Mason banking branch
Next Ground work under way for 141 townhomes, 63 houses in lightly developed Triad location